IL1B and acute myeloid leukemia: Accordingly, IL-1β has been identified as a key cytokine in inflammation-related myeloid malignancies, including acute myeloid leukemia (AML) and chronic (CML) myeloid leukemia, as it supports cellular expansion and hence disease progression [14,15].